Changes in whole metabolites after exenatide treatment in overweight/obese polycystic ovary syndrome patients.
Liang TangLei YuanGangyi YangFeng WangMao FuMin ChenDongfang LiuPublished in: Clinical endocrinology (2019)
NTGC-MS-based metabolic pathway analysis revealed that exenatide has a beneficial effect on overweight/obese PCOS patients by regulating metabolic disorders, especially amino acid disorders.
Keyphrases
- polycystic ovary syndrome
- end stage renal disease
- weight loss
- ejection fraction
- newly diagnosed
- adipose tissue
- peritoneal dialysis
- type diabetes
- insulin resistance
- prognostic factors
- metabolic syndrome
- ms ms
- amino acid
- patient reported outcomes
- body mass index
- weight gain
- patient reported
- smoking cessation
- replacement therapy